Financial News
Biomarin Pharmaceuticals (NQ: BMRN )
84.18
+0.09
(+0.11%)
Streaming Delayed Price
Updated: 10:02 AM EDT, Jul 22, 2024
Add to My Watchlist
Headline News about Biomarin Pharmaceuticals
![](https://cdn.benzinga.com/files/images/story/2022/11/03/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6675.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28905.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/31/image-mastercard.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/706594/scientist-looking-through-microscope-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28096.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/13/aapharma_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/07/aapharma_2.png?width=1200&height=800&fit=crop)
BioMarin Lays Off 4% Of Its Workforce To 'Simplify' The Company
October 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_164.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28900.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8987.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1441.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/04/aapharma.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_19908.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-biotech-12-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/aapharma_18.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/01/A1MAIN-biotech-011020-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/24/bz-pharma_4.jpg?width=1200&height=800&fit=crop)
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 24, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/24/bz-pharma_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_670.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/03/biotech10.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://www.investors.com/wp-content/uploads/2022/03/Stock-syringe-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_19913.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/22/biotech3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_15672.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_1147.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/09/biotech12.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/04/28/aapharma_12.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.